Look for:

Our offer for

ASTELLAS PHARMA INC.


ISIN:
JP3942400007
WKN:
4503
2024/10/31 15:23:48
Price
11.1275 USD
Difference -7.27% (-0.87)

General attributes

ISINJP3942400007
Symbol4503
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)19,284 EUR
BenchmarkNIKKEI 225

Market data

Bid (Bid size)-
Ask (Ask size)-
Open10.883 USD
High11.1275 USD
Low10.883 USD
Close (prev. day)12.00 USD
VWAP10.939423 USD
Volume (pcs)1,300
Trading volume14,221.25
Number of trades2
Last size300

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Annual report: ASTELLAS PHARMA INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/10/31 15:23:48
Price
11.1275 USD
Difference -7.27% (-0.87)

General attributes

ISINJP3942400007
Symbol4503
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)19,284 EUR
BenchmarkNIKKEI 225

Market data

Bid (Bid size)-
Ask (Ask size)-
Open10.883 USD
High11.1275 USD
Low10.883 USD
Close (prev. day)12.00 USD
VWAP10.939423 USD
Volume (pcs)1,300
Trading volume14,221.25
Number of trades2
Last size300

Performance and Risk

6M1Y3Y
Perf (%)---32.19%
Perf (abs.)---5.28
Beta0.300.290.47
Volatility48.2343.7132.03
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)11.3925 USD (1,244)
Ø price 30 days | Ø volume 30 days (pcs.)11.5099 USD (1,556)
Ø price 100 days | Ø volume 100 days (pcs.)10.9731 USD (2,673)
Ø price 250 days | Ø volume 250 days (pcs.)11.0854 USD (3,911)
YTD High | date12.7400 USD (2024/09/09)
YTD Low | date9.1300 USD (2024/04/16)
52 Weeks High | date12.7400 USD (2024/09/09)
52 Weeks Low | date9.1300 USD (2024/04/16)

All listings for ASTELLAS PHARMA INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/11/0112:0610.945 EUR0.002
Tokyo Stock Exchange2024/11/0107:001,781.50 JPY86.475,625
Stuttgart2024/11/0108:1310.66 EUR0.001
Munich2024/11/0108:0310.745 EUR0.001
Frankfurt2024/11/0109:0610.485 EUR0.001
FINRA other OTC Issues2024/10/3115:2311.1275 USD0.012
Duesseldorf2024/11/0109:3110.68 EUR0.002
Berlin2024/11/0110:0510.83 EUR0.003

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=3136&ID_TYPE_IMAGE_LOGO=2

Contact Details

ASTELLAS PHARMA INC.
- -
2-5-1 Nihonbashi-Honcho, Chuo-Ku - 103-8411 Tokyo
Telefon: +81-3-3244-3000
Fax: +
E-mail: -

PDF Downloads

Annual report: ASTELLAS PHARMA INC.PDF Download

Company Profile

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Members of Management Board

Kenji YasukawaChairman of Managing Board
Bernie ZeiherMember of Executive Committee
Catherine LevittMember of Executive Committee
Fumiaki SakuraiMember of Executive Committee
Hideki ShimaMember of Executive Committee
Minoru KikuokaMember of Executive Committee
Naoki OkamuraMember of Executive Committee
Yoshihtsugu ShitakaMember of Executive Committee
Yukio MatsuiMember of Executive Committee

Board of directors

Kenji YasukawaChairman of Supervisory Board
Eriko SakuraiMember of Supervisory Board
Haruko ShibumuraMember of Supervisory Board
Hiroko SakaiMember of Supervisory Board
Hiroo SasakiMember of Supervisory Board
Hiroshi KawabeMember of Supervisory Board
Katsuyoshi SugitaMember of Supervisory Board
Mamoru SekiyamaMember of Supervisory Board
Mika NakayamaMember of Supervisory Board
Noriyuki UematsuMember of Supervisory Board
Takashi TanakaMember of Supervisory Board
Tatsuro IshizukaMember of Supervisory Board
Tomokazu FujisawaMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.